Interestingly, four cytokines, sCD40L, MCP-1/CCL2, MIP-1b/CCL4, and PDGF-AA, were significantly changed in all three comparisons (HS vs. SLE, HS vs. MS, and SLE vs. MS). This evidence concerns the gene CCL2 and myeloid sarcoma.